The European Parliament voted against a list produced by the European Commission of criteria to help identify what are known as endocrine disruptors in products used to protect farm animals and plants from disease and insects.
Endocrine disruptors are believed to have a role in many health conditions, from obesity to infertility, and are found in many common goods such as cosmetics or even toys.
"Parliament blocked an EU Commission proposal which would have exempted some chemicals in pesticides from being identified as endocrine disruptors, on Wednesday," parliament said in a statement.
The setback came just three months after an apparent breakthrough in a three-year stand-off over the chemicals, when EU member states approved the commission's list.
EU Health Commissioner Vytenis Andriukaitis said in a statement that he "regrets" the parliament decision, adding that "in this case no deal is a bad deal for EU citizens."
"The commission will now need to reflect on next steps to take," he said.
The body's endocrine system -- in the ovaries and testes, as well as the adrenal, pituitary and thyroid glands -- produce hormones that are secreted into the bloodstream to control and coordinate a range of critical body functions.
The disruptors issue has pitted industry and agriculture against consumer and environmental groups for many years.
The EU even announced last year that it had reached broad agreement on what substances were involved but had to go back to the drawing board amid controversy.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
